メリーランド州における悪性黒色腫の臨床試験
メリーランド州内の拠点で、悪性黒色腫に関する24件の研究が参加者を募集しています。
メリーランド州内の都市
公式研究テキスト（英語）
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma
- National Cancer Institute (NCI), Bethesda
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究健康なボランティア歓迎
4 Weeks – 99 Years · 全性別 · 2026/10/02更新 · NCT00040352Evaluation for NCI Surgery Branch Clinical Research Protocols
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究
18歳以上 · 全性別 · 2026/10/02更新 · NCT00001823Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma
- National Institutes of Health Clinical Center, Bethesda
被験者募集中第2相
18歳〜120歳 · 全性別 · 2026/10/02更新 · NCT05155033Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- 他10件
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Johns Hopkins University, Baltimore
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06172478A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
- Maryland Oncology Hematology, P.A., Columbia
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06246916Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- National Cancer Institute, Bethesda
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT05727904Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- Christiana Care - Union Hospital, Elkton
被験者募集中第3相
75歳以上 · 全性別 · 2026/09/24更新 · NCT07068074A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
- National Institutes of Health Clinical Center, Bethesda
被験者募集中第1相
18歳〜120歳 · 全性別 · 2026/09/22更新 · NCT06066138A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Johns Hopkins Hospital, Baltimore
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07492680Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/31更新 · NCT05896839Project: Every Child for Younger Patients With Cancer
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- 他1件
被験者募集中観察研究
25歳以下 · 全性別 · 2026/08/25更新 · NCT02402244A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- National Institutes of Health Clinical Center, Bethesda
被験者募集中第2相
18歳〜72歳 · 全性別 · 2026/08/20更新 · NCT02621021Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- National Institutes of Health Clinical Center, Bethesda
被験者募集中第1/2相
18歳〜72歳 · 全性別 · 2026/08/13更新 · NCT02830724A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- National Institutes of Health, Bethesda
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/11更新 · NCT05592626Integrated Cancer Repository for Cancer Research
- Northwest Hospital, Randallstown
- William E. Kahlert Regional Cancer Center, Westminster
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
- Frederick Health Hospital, Frederick
被験者募集中観察研究
18歳以上 · 全性別 · 2026/06/29更新 · NCT07327489DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- USA11-0, Bethesda
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/22更新 · NCT06953089Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- Johns Hopkins University, Baltimore
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/15更新 · NCT05379985Neoadjuvant Darovasertib in Primary Uveal Melanoma
- Wilmer Eye Institute, Baltimore
被験者募集中第3相
18歳以上 · 全性別 · 2026/05/06更新 · NCT07015190Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- Christiana Care - Union Hospital, Elkton
- 他3件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Baltimore
- Massive Bio SYNERGY-AI site, Bethesda
- Massive Bio SYNERGY-AI site, Silver Spring
- 他1件
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774Excision of Lymph Node Trial (EXCILYNT) (Mel69)
- University of Maryland, Baltimore
被験者募集中
18歳以上 · 全性別 · 2025/09/17更新 · NCT05839912Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- MedStar Franklin Square Medical Center, Baltimore
被験者募集中
18歳以上 · 全性別 · 2024/11/27更新 · NCT03860883ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。